Fig. 1 · Structure

Documents & Downloads

VPC-70063

Myc-Max Inhibitor

VPC-70063 is a selective Myc-Max inhibitor that effectively disrupts Myc-Max transcriptional activity with an IC50 of 8.9 μM. This compound has been shown to reduce UBE2C promoter activity and AR-V7 levels while inducing PARP cleavage, contributing to its pro-apoptotic effects. VPC-70063 serves as a valuable tool for investigating the mechanisms of cancer progression and potential therapeutic strategies targeting the Myc-Max interaction.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 13571-44-3
Applications Myc-Max Inhibitor
Formula C16H12F6N2S
Molecular Weight 378.34
SMILES
FC(F)(C1=CC(NC(NCC2=CC=CC=C2)=S)=CC(C(F)(F)F)=C1)F

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...